杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 10 2026

Full Issue

At GSK's Request, FDA Rescinds Drug That Trump Touted To Treat Autism

The generic version of Wellcovorin is still available to cerebral folate deficiency patients. More administration news is about EPA rules on coal plant ash, the surgeon general nominee, potentially deeper health care cuts, and more.

US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug. The Food and Drug Administration is pulling its approval of Wellcovorin, a branded version of leucovorin from GSK Plc, according to a post Thursday in the Federal Register. GSK had requested that the approval be withdrawn, the post said. (Smith, 4/9)

More news about the Trump administration 鈥

The Trump administration on Thursday proposed weakening rules for the disposal of ash produced by burning coal that can contain hazardous heavy metals and contaminate groundwater. Those regulations were strengthened under the Biden administration as part of a wider crackdown on pollution from coal-fired power plants. The Trump administration proposed easing standards for monitoring and protecting groundwater near some coal ash sites, and rolling back rules that require the cleanup of entire coal properties rather than just the sites where ash was dumped. The revisions would also make it easier to reuse coal ash for other purposes. (Phillis and St. John, 4/9)

President Trump met privately on Thursday with leaders of Health Secretary Robert F. Kennedy Jr.鈥檚 鈥淢ake America Healthy Again鈥 movement as part of a high-level White House strategy session to keep disenchanted MAHA voters in the fold ahead of the midterm elections. Neither the White House nor Mr. Kennedy鈥檚 office would provide details of the meeting. (Gay Stolberg, 4/9)

Senior White House adviser Calley Means said on Thursday that 鈥渃onversations are ongoing鈥 amid doubts over whether his sister, surgeon general nominee Casey Means, has enough votes in the Senate for confirmation. Calley Means was asked during an appearance on NewsNation鈥檚 鈥淭he Hill鈥 whether the White House still expected Casey Means to be the next surgeon general after President Trump recently indicated he was open to withdrawing her nomination. (Brams, 4/9)

U.S. abortion opponents are increasingly frustrated with the lack of action by President Donald Trump鈥檚 administration to stem the flow of abortion pills prescribed online that they view as undermining state abortion bans. A court ruling this week in a lawsuit the Louisiana attorney general brought against Trump鈥檚 Food and Drug Administration cast a spotlight on the simmering tension. The judge said the state has a strong case while declining to block telehealth prescriptions to the pill mifepristone for now. (Mulvihill and Perrone, 4/9)

杨贵妃传媒視頻 Health News: 杨贵妃传媒視頻 Health News鈥 鈥榃hat The Health?鈥: Abortion Pills, The Budget, And RFK Jr

At the Trump administration鈥檚 request, a federal judge in Louisiana this week agreed to delay a ruling affecting the continued availability of the abortion drug mifepristone. That angered anti-abortion groups that want the drug, if not banned, at least more strictly controlled. But the administration clearly wants to avoid big abortion fights in the run-up to November鈥檚 midterm elections. (Rovner, 4/9)

From Capitol Hill 鈥

Hospitals are still absorbing the financial shock of last summer鈥檚 One Big Beautiful Bill Act, and Capitol Hill is already preparing another round of federal funding cuts. Republican lawmakers have agreed on a two-track plan to fund the Department of Homeland Security and immigration enforcement, with healthcare spending once again in the crosshairs as a funding offset. The House blocked the DHS portion on April 2 and is now in recess until April 14, a sign of the internal GOP friction that could complicate 鈥 but is unlikely to stop 鈥 the broader effort, according to The New York Times. (Condon, 4/9)

Former Sen. Ben Sasse (R-Neb.) detailed his battle with cancer and reflected on his life during a wide-ranging interview with The New York Times鈥檚 Ross Douthat. The conversation, released Thursday as part of Douthat鈥檚 鈥淚nteresting Times鈥 podcast, took place less than four months after Sasse revealed his Stage 4 pancreatic cancer diagnosis.鈥 In mid-December I got a three- to four-month life expectancy, and I鈥檓 at Day 99 or something since then, and I鈥檓 doing a heck of a lot better than I was doing at Christmas,鈥 he told the host. (Rego, 4/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF